Similar articles

• Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

  Robinson GV, Stradling JR, Davies RJ. Robinson GV, et al. Thorax. 2004 Dec;59(12):1089-94. doi: 10.1136/thx.2003.015875. Thorax. 2004. PMID: 15563710 Free PMC article. Review.
• [Cardiovascular consequences of obstructive sleep apnoea syndrome].

  Kohler M, Russi EW, Bloch KE. Kohler M, et al. Praxis (Bern 1994). 2010 Jan 20;99(2):117-22. doi: 10.1024/1661-8157/a000014. Praxis (Bern 1994). 2010. PMID: 20087831 Review. German.
• The role of continuous positive airway pressure in the treatment of hypertension in patients with obstructive sleep apnea-hypoapnea syndrome: a review of randomized trials.

  Rao M, Rajda G, Uppuluri S, Beck GR, Liu L, Bisognano JD. Rao M, et al. Rev Recent Clin Trials. 2010 Jan;5(1):35-42. doi: 10.2174/157488710790820526. Rev Recent Clin Trials. 2010. PMID: 20205686 Review.
• Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy.

  Tsioufis C, Kasiakogias A, Thomopoulos C, Manolis A, Stefanadis C. Tsioufis C, et al. J Hypertens. 2010 May;28(5):875-82. doi: 10.1097/HJH.0b013e328336ed85. J Hypertens. 2010. PMID: 20087211 Review.
• Obstructive sleep apnoea as a cause of nocturnal nondipping blood pressure: recent evidence regarding clinical importance and underlying mechanisms.

  Crinion SJ, Ryan S, McNicholas WT. Crinion SJ, et al. Eur Respir J. 2017 Jan 11;49(1):1601818. doi: 10.1183/13993003.01818-2016. Print 2017 Jan. Eur Respir J. 2017. PMID: 28077479 No abstract available.